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Abstract
GeneMill ofﬁcially launched on 4th February 2016 and is an open access academic facility located at
The University of Liverpool that has been established for the high-throughput construction and testing of
synthetic DNA constructs. GeneMill provides end-to-end design, construction and phenotypic characterization
of small to large gene constructs or genetic circuits/pathways for academic and industrial applications. Thus,
GeneMill is equipping the scientiﬁc community with easy access to the validated tools required to explore
the possibilities of Synthetic Biology.
GeneMill is part of the wider Centre for Genomic Research
(CGR) atUniversity of Liverpool, which is a dedicated centre
that facilitates academic and industrial access to state-of-
the-art sequencing technologies for researchers worldwide.
The success of the CGR over the past 10 years has led
to further investment and development, now including
Synthetic Biology.GeneMillwas originally fundedbyRCUK
in 2014 as one of the five UK DNA Foundries to set up a
high-throughputDNA fabrication facility. Synthetic Biology
is built on the principle of iterative cycles of Design-Build-
Test-Learn and hencewe have since developed significantly to
include phenotyping platforms to close that loop (Figure 1).
Thus, projects benefit not only from rapid sequence-perfect
DNA construct/library synthesis, but also from the ability to
assay the functionality of the synthesizedDNA in the context
of multiple hosts/chassis and culture conditions.
Design
The focus and goal of GeneMill is to remove the complexity
from the end user. DNA constructs can be designed by
function rather than, as is traditional, by DNA sequence.
Thus, the user simply needs to know the desired outcome
of the designed construct, not the exact nucleotide sequence.
Standardization and detailed annotation/ characterization of
functional DNA parts (promoters, ribosome-binding sites,
tags, terminators etc.) are key to achieving this goal [1].
GeneMill is workingwith other SynBio centres and thewider
scientific community to develop consistent nomenclature and
annotation rules on function and efficacy so that these parts
can be designed, shared and used interchangeably throughout
the community [2]. This takes a large step to reducing
the current levels of variability in data produced from one
laboratory to the next, encourages use of standard defined
components and prevents the reinvention of ideas across
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different research groups. A repository of these functional
parts is being produced and housed within GeneMill and will
be accessed through a design portal, which will be available
online in the coming months (Figure 1). This will take the
form of a web-based graphical user interface, where users
will also be able to track the progress of the project through
the same online interface.Novel or custom sequences can also
be requested here, as users will not be limited to predefined
parts which could be added to GeneMill’s growing parts
repository. We will continue to work with academics from
various research communities to build up a large repertoire
of defined parts, which will benefit their community as
a whole, increase impact and provide a lasting legacy [3].
Additionally, for non-community led projects, we have in-
house established bioinformatics expertise in metagenomics,
transcriptomic analysis and data mining to complete an end-
to-end pipeline from pathway discovery to synthetic design.
Industrial collaborators who wish to have private collections
are also accommodated, and these will not be shared with the
wider scientific community.
Build
We take the final in silico DNA construct design and
split it into its constituent parts. We have partnered with
Twist Bioscience and GeneArt (Thermo Fisher Scientific) for
DNA synthesis, which will produce the individual parts. In
addition, we are working as part of a consortium to develop
methods for higher fidelity oligonucleotide synthesis. All
blocks and complete constructs will be stored in individually
2D-barcoded tubes, placed in an automated TTP Labtech
Arktic − 80 ◦C freezer. Although this system has a small
footprint, it holds>140000 tubes, storing and retrieving each
one quickly and securely. Constituent parts are assembled
together to form complete DNA constructs. To maximize
efficiency of the assembly process, we are using ultra-low
volume liquid handlers; the Labcyte Echo liquid handler
uses acoustic energy, whereas TTP Labtech Mosquito liquid
handlers use positive displacement tips to transfer nanolitre-
scale volumes. This increases speed, reduces reagent volumes
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Figure 1 GeneMill overview
DNA constructs are designed in silico. Functional parts are synthesized or retrieved from the automated storage and then
combined at the nl scale with automated liquid handlers. DNA assembly reactions and transformations are performed,
colonies picked and positive clones are taken forward for sequencing. Constructs are then assayed for function by small-scale
culture or high thoughput (HT) micro-fermentation before being passed on for biochemical assays or metabolite analysis.
Data can then be used to assess the function of the construct and/or host and potentially taken on for further design and
optimization. Text Box borders indicate funding source; Red=GeneMill DNA Foundry, Purple=Assay Development Platform,
Green=NextGen DNA Synthesis.
and eliminates cross-contamination. We are working closely
with other U.K. Foundries to optimize these nanolitre-scale
methods [4]. Standardization across multiple sites of these
fundamental processes allows sharing of methods as well
as DNA parts. A liquid handling robotics system, based
around two CyBio FeliXs is then used to fabricate the
final construct using high efficiency enzymatic assembly
techniques [5]. This robot can perform automated thermal
cycling and incubations to automate the transformation
and plating of bacteria. A standalone K-Biosystems K6-2
system then identifies and picks colonies for culture and
PCR-based QC via automated electrophoresis on Qiagen
and Agilent instruments. DNA constructs pass through a
stringent final QC stage where their sequences are verified.
As part of the CGR, GeneMill has access to Next Generation
sequencing technologies as well as long-read (>30 kb) single
molecule sequencing allowing validation of sequence fidelity
and assembly process.
The ability to automate the workflow described above
guarantees reproducibility and standardization of DNA
construct fabrication. It also means that protocols can be
shared between sites and allow an identical workflow to
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be carried out. This eliminates the inevitable variability
introduced by human scientists and removes the ‘art’ from
molecular biology, reducing the time spent on cloning and
allowing more of the investigators’ time to be spent on
answering the important scientific questions [6].
Test
As mentioned above, GeneMill not only provides an
accessible DNA fabrication facility, we are also working
closely with the Edinburgh Genome Foundry to develop
pipelines for phenotypic analyses of novel proteins or syn-
thetic pathways. From small-scale protein purification and
enzyme prototyping to high-throughputmicro-fermentation
and metabolomics, GeneMill has an array of testing
methodologies available. The RoboLector from M2P-Labs,
for example provides a unique automatedmicro-fermentation
system combining the high-throughput fermentation and
online monitoring capabilities of the micro-bioreactor
with automated sampling and control from the liquid
handling robot. The online acquisition of relevant bioprocess
data including biomass, fluorescent tag expression and
culture oxygenation, allows precise and reliable bioprocess
development, strain characterization, media optimization,
direct up-scalability and clone screening in short time frames
[7,8].
Metabolites of different samples, from individual bacterial
colonies to cultures from a time course, can be analysed in
great detail with our MS facilities. We have partnered with
Agilent Technologies to equip GeneMill with the tools to
examine a full range of metabolites. LC, GC or supercritical
fluid chromatography (SFC) instruments upstream of an ion
mobility-quantitative time-of-flight mass spectrometer (IM-
QTOF MS) optimized for metabolic fingerprinting give us
the ability to accurately identifymetabolites of any type from
complex sample mixtures [9]. Additionally, standard liquid
chromatography-coupled mass spectrometry (LCMS) and
gas chromatography-coupled mass spectrometry (GCMS)
systems are available. These powerful techniques are key as
they allow detailed interrogation and optimization of the
fitness of each engineered strain or synthetic clone, from
individual enzymes to entire synthetic pathways.
Learn
Data gained from the techniques above can then be used to
optimize the construct or host cell. For example MS data can
be mapped to known biochemical pathways and combined
and overlaid with other types of OMIC data to build up a
detailed overview of cellular processes. We can then see the
synthetic component as part of the whole system, rather than
in isolation. Hosts as well as DNA constructs can then be
optimized further.
The focus of GeneMill and the described workflow is
available to the scientific community. Projects undertaken
include the following: DNA fabrication, (plasmids, libraries
and genome editing tools), expression optimization and
designer proteins, enzyme prototyping, culture optimization,
bioreactor scale-up andmetabolic fingerprinting. Projects are
managed from initial discussion to completion. Services are
performed by postdoctoral GeneMill staff or by individual
users gaining access to equipment and expertise in GeneMill
labs (‘residential’). Alternatively, for larger projects, a
dedicated member of staff may be recruited specifically to
handle the project. We are also keen to work with whole
communities to help build sets of parts for a specific organism
or technology. These can then be delivered via the GeneMill
as bespoke constructs.
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